Cargando…
Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors
Drug-resistant superbugs pose a huge threat to human health. Infections by Enterobacteriaceae producing metallo-β-lactamases (MBLs), e.g., New Delhi metallo-β-lactamase 1 (NDM-1) are very difficult to treat. Development of effective MBL inhibitors to revive the efficacy of existing antibiotics is hi...
Autores principales: | Wang, Runming, Lai, Tsz-Pui, Gao, Peng, Zhang, Hongmin, Ho, Pak-Leung, Woo, Patrick Chiu-Yat, Ma, Guixing, Kao, Richard Yi-Tsun, Li, Hongyan, Sun, Hongzhe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5789847/ https://www.ncbi.nlm.nih.gov/pubmed/29382822 http://dx.doi.org/10.1038/s41467-018-02828-6 |
Ejemplares similares
-
Metallo-sideromycin as a dual functional complex for combating antimicrobial resistance
por: Wang, Chenyuan, et al.
Publicado: (2023) -
Bismuth: Environmental Pollution and Health Effects
por: Wang, Runming, et al.
Publicado: (2019) -
Broad spectrum antibiotic-degrading metallo-β-lactamases are phylogenetically diverse
por: Pedroso, Marcelo Monteiro, et al.
Publicado: (2020) -
Orally administered bismuth drug together with N-acetyl cysteine as a broad-spectrum anti-coronavirus cocktail therapy
por: Wang, Runming, et al.
Publicado: (2021) -
Discovery of mercaptopropanamide-substituted aryl tetrazoles as new broad-spectrum metallo-β-lactamase inhibitors
por: Yan, Yu-Hang, et al.
Publicado: (2020)